Our findings contribute to filling this gap, demonstrating that glucagon’s interactions with both the GCGR and GLP-1R add complexity to its role in cancer biology, potentially driving adaptive mechanisms in pNET cells [40,41,42,43]. The gene discussed is GLP1R; the disease is cancer.